Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2018 at "Bone"
DOI: 10.1016/j.bone.2018.04.004
Abstract: BACKGROUND Fracture risk is increased in individuals with type 2 diabetes (T2D). The pathophysiological mechanisms accentuating fracture risk in T2D are convoluted, incorporating factors such as hyperglycaemia, insulinopenia, and antidiabetic drugs. The objectives of this… read more here.
Keywords: insulin; metformin rosiglitazone; bone; type diabetes ... See more keywords